CD8A and neoplasm: Subsequently, Chen et al. discovered that combining Alarmin HMGN1 peptide with PD-L1 blockade therapy promotes the proliferation and activates the anti-tumor activity of stem-like/progenitor-exhausted CD8+ T (Tstem/Tpex) cells [85].